STAT Plus: What’s at stake for industry in the pharmaceutical Space Race for a Covid-19 vaccine
The Trump administration’s move to pick five companies as finalists in the quest to develop a vaccine for the novel coronavirus has set off a pharmaceutical Space Race in the industry. And for each of the five firms involved, there’s a lot at stake: reputation, a boon to national pride, maybe even a rebuke to voluble skeptics.
Coming in first could help, too.
Continue to STAT Plus to read the full story…
